Abstract
Modification of cerebrospinal fluid (CSF) transport dynamics is an expanding method for treating central nervous system injury and diseases. One application of this route is to modify the distribution of solutes in the CSF; however, few tools currently exist for this purpose. The present study describes the use of a subject-specific in vitro CSF phantom to perform a parametric evaluation of the Neurapheresis™ CSF Management System (NP) for both CSF filtration and intrathecal drug circulation. An in vitro CSF phantom was constructed which included realistic anatomy for the complete subarachnoid space (SAS). This platform was configured to test multiple parametric modifications of a dual-lumen catheter and filtration system. Calibrated mapping of tracer distribution and area under the curve (AUC) measurements were used to compare filtration and intrathecal-circulation schemes using the NP device versus the clinical standards of care. The NP device showed potential advantages over lumbar drain (LD) for clearance of simulated subarachnoid hemorrhage (SAH), especially in the spinal canal. Use of the NP device in combination with simulated intracerebroventricular (ICV) drug infusion resulted in an increased extent and uniformity of tracer spread compared to ICV alone. NP improved clearance of simulated subarachnoid hemorrhage compared to LD and increased uniformity of tracer concentration via simulated ICV, providing support for NP use in these scenarios. The in vitro CSF phantom system presented here quantitatively described the effects of parametric boundary modification on solute distribution in the intrathecal space.
References
1.
Pardridge
, W. M.
, 2005
, “The Blood-Brain Barrier: Bottleneck in Brain Drug Development
,” NeuroRx
, 2
(1
), pp. 3
–14
.10.1602/neurorx.2.1.32.
Engelhardt
, B.
, and Sorokin
, L.
, 2009
, “The Blood-Brain and the Blood-Cerebrospinal Fluid Barriers: Function and Dysfunction
,” Semin. Immunopathol.
, 31
(4
), pp. 497
–511
.10.1007/s00281-009-0177-03.
Markowicz-Piasecka
, M.
, Darłak
, P.
, Markiewicz
, A.
, Sikora
, J.
, Kumar Adla
, S.
, Bagina
, S.
, and Huttunen
, K. M.
, 2022
, “Current Approaches to Facilitate Improved Drug Delivery to the Central Nervous System
,” Eur. J. Pharm. Biopharm.
, 181
, pp. 249
–262
.10.1016/j.ejpb.2022.11.0034.
De Andres
, J.
, Hayek
, S.
, Perruchoud
, C.
, Lawrence
, M. M.
, Reina
, M. A.
, De Andres-Serrano
, C.
, Rubio-Haro
, R.
, Hunt
, M.
, and Yaksh
, T. L.
, 2022
, “Intrathecal Drug Delivery: Advances and Applications in the Management of Chronic Pain Patient
,” Front. Pain Res. (Lausanne)
, 3
, p. 900566
.10.3389/fpain.2022.9005665.
Muldoon
, L. L.
, Soussain
, C.
, Jahnke
, K.
, Johanson
, C.
, Siegal
, T.
, Smith
, Q. R.
, Hall
, W. A.
, et al., 2007
, “Chemotherapy Delivery Issues in Central Nervous System Malignancy: A Reality Check
,” J. Clin. Oncol.
, 25
(16
), pp. 2295
–2305
.10.1200/JCO.2006.09.98616.
Prakash
, V.
, 2017
, “Spinraza—A Rare Disease Success Story
,” Gene Ther.
, 24
(9
), p. 497
.10.1038/gt.2017.597.
Menendez-Gonzalez
, M.
, Padilla-Zambrano
, H. S.
, Alvarez
, G.
, Capetillo-Zarate
, E.
, Tomas-Zapico
, C.
, and Costa
, A.
, 2018
, “Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer's Disease
,” Front. Aging Neurosci.
, 10
, p. 100
.10.3389/fnagi.2018.001008.
Wollinsky
, K. H.
, Hulser
, P. J.
, Brinkmeier
, H.
, Mehrkens
, H. H.
, Kornhuber
, H. H.
, and Rudel
, R.
, 1994
, “Filtration of Cerebrospinal Fluid in Acute Inflammatory Demyelinating Polyneuropathy (Guillain-Barre Syndrome)
,” Ann. Med. Interne (Paris)
, 145
(7
), pp. 451
–458
.www.pubmed.ncbi.nlm.nih.gov/7864511/9.
Van Horn
, A.
, and Chamberlain
, M. C.
, 2012
, “Neoplastic Meningitis
,” J. Support Oncol.
, 10
(2
), pp. 45
–53
.10.1016/j.suponc.2011.06.00210.
Bomgaars
, L.
, Chamberlain
, M. C.
, Poplack
, D. G.
, and Blaney
, S. M.
, 2002
, “Leptomeningeal Metastases
,” Cancer in the Nervous System
, Oxford University Press
, Oxford, UK, pp. 375
–394
.11.
Scott
, B. J.
, van Vugt
, V. A.
, Rush
, T.
, Brown
, T.
, Chen
, C. C.
, Carter
, B. S.
, Schwab
, R.
, et al., 2014
, “Concurrent Intrathecal Methotrexate and Liposomal Cytarabine for Leptomeningeal Metastasis From Solid Tumors: A Retrospective Cohort Study
,” J. Neurooncol.
, 119
(2
), pp. 361
–368
.10.1007/s11060-014-1486-212.
Hsu
, Y.
, Hettiarachchi
, H. D.
, Zhu
, D. C.
, and Linninger
, A. A.
, 2012
, “The Frequency and Magnitude of Cerebrospinal Fluid Pulsations Influence Intrathecal Drug Distribution: Key Factors for Interpatient Variability
,” Anesth. Analg.
, 115
(2
), pp. 386
–394
.10.1213/ANE.0b013e318253621113.
Linninger
, A. A.
, Tsakiris
, C.
, Zhu
, D. C.
, Xenos
, M.
, Roycewicz
, P.
, Danziger
, Z.
, and Penn
, R.
, 2005
, “Pulsatile Cerebrospinal Fluid Dynamics in the Human Brain
,” IEEE Trans. Biomed. Eng.
, 52
(4
), pp. 557
–565
.10.1109/TBME.2005.84402114.
Fleischhack
, G.
, Jaehde
, U.
, and Bode
, U.
, 2005
, “Pharmacokinetics Following Intraventricular Administration of Chemotherapy in Patients With Neoplastic Meningitis
,” Clin. Pharmacokinet.
, 44
(1
), pp. 1
–31
.10.2165/00003088-200544010-0000115.
Balis
, F. M.
, Blaney
, S. M.
, McCully
, C. L.
, Bacher
, J. D.
, Murphy
, R. F.
, and Poplack
, D. G.
, 2000
, “Methotrexate Distribution Within the Subarachnoid Space After Intraventricular and Intravenous Administration
,” Cancer Chemother. Pharmacol.
, 45
(3
), pp. 259
–264
.10.1007/s00280005003816.
Moser
, A. M.
, Adamson
, P. C.
, Gillespie
, A. J.
, Poplack
, D. G.
, and Balis
, F. M.
, 1999
, “Intraventricular Concentration Times Time (C x T) Methotrexate and Cytarabine for Patients With Recurrent Meningeal Leukemia and Lymphoma
,” Cancer
, 85
(2
), pp. 511
–516
.10.1002/(SICI)1097-0142(19990115)85:2<511::AID-CNCR33>3.0.CO;2-H17.
Pinedo
, H. M.
, and Chabner
, B. A.
, 1977
, “Role of Drug Concentration, Duration of Exposure, and Endogenous Metabolites in Determining Methotrexate Cytotoxicity
,” Cancer Treat. Rep.
, 61
(4
), pp. 709
–715
.www.pubmed.ncbi.nlm.nih.gov/884693/https://doi.org/pubmed.ncbi.nlm.nih.gov/884693/18.
Zeineddine
, H. A.
, Honarpisheh
, P.
, McBride
, D.
, Pandit
, P. K. T.
, Dienel
, A.
, Hong
, S. H.
, Grotta
, J.
, and Blackburn
, S.
, 2022
, “Targeting Hemoglobin to Reduce Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
,” Transl. Stroke Res.
, 13
(5
), pp. 725
–735
.10.1007/s12975-022-00995-919.
Macdonald
, R. L.
, 2014
, “Delayed Neurological Deterioration After Subarachnoid Haemorrhage
,” Nat. Rev. Neurol.
, 10
(1
), pp. 44
–58
.10.1038/nrneurol.2013.24620.
Clark
, J. F.
, and Sharp
, F. R.
, 2006
, “Bilirubin Oxidation Products (BOXes) and Their Role in Cerebral Vasospasm After Subarachnoid Hemorrhage
,” J. Cereb. Blood Flow Metab.
, 26
(10
), pp. 1223
–1233
.10.1038/sj.jcbfm.960028021.
Stokum
, J. A.
, Cannarsa
, G. J.
, Wessell
, A. P.
, Shea
, P.
, Wenger
, N.
, and Simard
, J. M.
, 2021
, “When the Blood Hits Your Brain: The Neurotoxicity of Extravasated Blood
,” Int. J. Mol. Sci.
, 22
(10
), p. 5132
.10.3390/ijms2210513222.
Wolf
, S.
, Mielke
, D.
, Barner
, C.
, Malinova
, V.
, Kerz
, T.
, Wostrack
, M.
, Czorlich
, P.
, et al., 2023
, “Effectiveness of Lumbar Cerebrospinal Fluid Drain Among Patients With Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial
,” JAMA Neurol.
, 80
(8
), pp. 833
–842
.10.1001/jamaneurol.2023.179223.
Alcalá-Cerra
, G.
, Paternina-Caicedo
, Á.
, Díaz-Becerra
, C.
, Moscote-Salazar
, L. R.
, Gutiérrez-Paternina
, J. J.
, and Niño-Hernández
, L. M.
, 2016
, “External Lumbar Cerebrospinal Fluid Drainage in Patients With Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Controlled Trials
,” Neurologia
, 31
(7
), pp. 431
–444
.10.1016/j.nrl.2014.01.00524.
Panni
, P.
, Fugate
, J. E.
, Rabinstein
, A. A.
, and Lanzino
, G.
, 2017
, “Lumbar Drainage and Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review
,” J. Neurosurg. Sci.
, 61
(6
), pp. 665
–672
.25.
Al-Tamimi
, Y. Z.
, Bhargava
, D.
, Feltbower
, R. G.
, Hall
, G.
, Goddard
, A. J.
, Quinn
, A. C.
, and Ross
, S. A.
, 2012
, “Lumbar Drainage of Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage: A Prospective, Randomized, Controlled Trial (LUMAS)
,” Stroke
, 43
(3
), pp. 677
–682
.10.1161/STROKEAHA.111.62573126.
Spector
, R.
, Keep
, R. F.
, Robert Snodgrass
, S.
, Smith
, Q. R.
, and Johanson
, C. E.
, 2015
, “A Balanced View of Choroid Plexus Structure and Function: Focus on Adult Humans
,” Exp. Neurol.
, 267
, pp. 78
–86
.10.1016/j.expneurol.2015.02.03227.
Chazen
, J. L.
, Dyke
, J. P.
, Holt
, R. W.
, Horky
, L.
, Pauplis
, R. A.
, Hesterman
, J. Y.
, Mozley
, D. P.
, and Verma
, A.
, 2017
, “Automated Segmentation of MR Imaging to Determine Normative Central Nervous System Cerebrospinal Fluid Volumes in Healthy Volunteers
,” Clin. Imaging
, 43
, pp. 132
–135
.10.1016/j.clinimag.2017.02.00728.
Pollay
, M.
, 2010
, “The Function and Structure of the Cerebrospinal Fluid Outflow System
,” Cerebrospinal Fluid Res.
, 7
, p. 9
.10.1186/1743-8454-7-929.
Dhaliwal
, J.
, Ruiz-Perez
, M.
, Mihaela-Vasilica
, A.
, Chari
, A.
, Hill
, C. S.
, and Thorne
, L.
, 2023
, “Survival and Quality of Life After CSF Diversion in Adult Patients With Leptomeningeal Metastasis-Associated Hydrocephalus: A Systematic Review and Meta-Analysis
,” Neurosurg. Focus
, 55
(2
), p. E16
.10.3171/2023.5.FOCUS2319530.
Heuer
, G. G.
, Smith
, M. J.
, Elliott
, J. P.
, Winn
, H. R.
, and LeRoux
, P. D.
, 2004
, “Relationship Between Intracranial Pressure and Other Clinical Variables in Patients With Aneurysmal Subarachnoid Hemorrhage
,” J. Neurosurg.
, 101
(3
), pp. 408
–416
.10.3171/jns.2004.101.3.040831.
Blackburn
, S. L.
, Grande
, A. W.
, Swisher
, C. B.
, Hauck
, E. F.
, Jagadeesan
, B.
, and Provencio
, J. J.
, 2019
, “Prospective Trial of Cerebrospinal Fluid Filtration After Aneurysmal Subarachnoid Hemorrhage Via Lumbar Catheter (PILLAR)
,” Stroke
, 50
(9
), pp. 2558
–2561
.10.1161/STROKEAHA.119.02539932.
Khani
, M.
, Sass
, L. R.
, McCabe
, A. R.
, Zitella Verbick
, L. M.
, Lad
, S. P.
, Sharp
, M. K.
, and Martin
, B. A.
, 2020
, “Impact of Neurapheresis System on Intrathecal Cerebrospinal Fluid Dynamics: A Computational Fluid Dynamics Study
,” ASME J. Biomech. Eng.
, 142
(2
), p. 021006
.10.1115/1.404430833.
Bretz
, J. S.
, Von Dincklage
, F.
, Woitzik
, J.
, Winkler
, M. K. L.
, Major
, S.
, Dreier
, J. P.
, Bohner
, G.
, and Scheel
, M.
, 2017
, “The Hijdra Scale Has Significant Prognostic Value for the Functional Outcome of Fisher Grade 3 Patients With Subarachnoid Hemorrhage
,” Clin. Neuroradiol.
, 27
(3
), pp. 361
–369
.10.1007/s00062-016-0509-034.
Norden
, A. G. W.
, Dijk
, G. W.
, Huizen
, M. D.
, Algra
, A.
, and Rinkel
, G. J. E.
, 2006
, “Interobserver Agreement and Predictive Value for Outcome of Two Rating Scales for the Amount of Extravasated Blood After Aneurysmal Subarachnoid Haemorrhage
,” J. Neurol.
, 253
(9
), pp. 1217
–1220
.10.1007/s00415-006-0205-035.
Khani
, M.
, Sass
, L. R.
, Sharp
, M. K.
, McCabe
, A. R.
, Zitella Verbick
, L. M.
, Lad
, S. P.
, and Martin
, B. A.
, 2020
, “In Vitro and Numerical Simulation of Blood Removal From Cerebrospinal Fluid: Comparison of Lumbar Drain to Neurapheresis Therapy
,” Fluids Barriers CNS
, 17
(1
), p. 23
.10.1186/s12987-020-00185-536.
Sass
, L. R.
, Khani
, M.
, Natividad
, G. C.
, Tubbs
, R. S.
, Baledent
, O.
, and Martin
, B. A.
, 2017
, “A 3D Subject-Specific Model of the Spinal Subarachnoid Space With Anatomically Realistic Ventral and Dorsal Spinal Cord Nerve Rootlets
,” Fluids Barriers CNS
, 14
(1
), p. 36
.10.1186/s12987-017-0085-y37.
Borkar
, S. A.
, Singh
, M.
, Kale
, S. S.
, Suri
, A.
, Chandra
, P. S.
, Kumar
, R.
, Sharma
, B. S.
, Gaikwad
, S.
, and Mahapatra
, A. K.
, 2018
, “Spinal Cerebrospinal Fluid Drainage for Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage: A Prospective, Randomized Controlled Study
,” Asian J. Neurosurg.
, 13
(2
), pp. 238
–246
.38.
Khani
, M.
, Sass
, L. R.
, Xing
, T.
, Keith Sharp
, M.
, Baledent
, O.
, and Martin
, B. A.
, 2018
, “Anthropomorphic Model of Intrathecal Cerebrospinal Fluid Dynamics Within the Spinal Subarachnoid Space: Spinal Cord Nerve Roots Increase Steady-Streaming
,” ASME J. Biomech. Eng.
, 140
(8
), p. 081012
.10.1115/1.404040139.
Damkier
, H. H.
, Brown
, P. D.
, and Praetorius
, J.
, 2013
, “Cerebrospinal Fluid Secretion by the Choroid Plexus
,” Physiol. Rev.
, 93
(4
), pp. 1847
–1892
.10.1152/physrev.00004.201340.
Pope
, J. E.
, Deer
, T. R.
, Bruel
, B. M.
, and Falowski
, S.
, 2016
, “Clinical Uses of Intrathecal Therapy and Its Placement in the Pain Care Algorithm
,” Pain Pract.
, 16
(8
), pp. 1092
–1106
.10.1111/papr.1243841.
Coenen
, W.
, Gutiérrez-Montes
, C.
, Sincomb
, S.
, Criado-Hidalgo
, E.
, Wei
, K.
, King
, K.
, Haughton
, V.
, Martínez-Bazán
, C.
, Sánchez
, A. L.
, and Lasheras
, J. C.
, 2019
, “Subject-Specific Studies of CSF Bulk Flow Patterns in the Spinal Canal: Implications for the Dispersion of Solute Particles in Intrathecal Drug Delivery
,” AJNR Am. J. Neuroradiol.
, 40
(7
), pp. 1242
–1249
.10.3174/ajnr.A609742.
Khani
, M.
, Burla
, G. K. R.
, Sass
, L. R.
, Arters
, O. N.
, Xing
, T.
, Wu
, H.
, and Martin
, B. A.
, 2022
, “Human In Silico Trials for Parametric Computational Fluid Dynamics Investigation of Cerebrospinal Fluid Drug Delivery: Impact of Injection Location, Injection Protocol, and Physiology
,” Fluids Barriers CNS
, 19
(1
), p. 8
.10.1186/s12987-022-00304-443.
Hollister
, J. C. P.
, Wang
, A. C.
, Kim
, W.
, Giza
, C. C.
, Prins
, M. L.
, and Kavehpour
, H. P.
, 2023
, “Shear Thinning Behavior of Cerebrospinal Fluid With Elevated Protein or Cellular Concentration
,” Front. Phys.
, 11
, p. 1308136
.10.3389/fphy.2023.130813644.
Bloomfield
, I. G.
, Johnston
, I. H.
, and Bilston
, L. E.
, 1998
, “Effects of Proteins, Blood Cells and Glucose on the Viscosity of Cerebrospinal Fluid
,” Pediatr. Neurosurg.
, 28
(5
), pp. 246
–251
.10.1159/00002865945.
Taye
, M. A.
, 2020
, “Sedimentation Rate of Erythrocyte From Physics Prospective
,” Eur. Phys. J. E: Soft Matter
, 43
(3
), p. 19
.10.1140/epje/i2020-11943-246.
Seiner
, A.
, Burla
, G. K. R.
, Shrestha
, D.
, Bowen
, M.
, Horvath
, J. D.
, and Martin
, B. A.
, 2022
, “Investigation of Human Intrathecal Solute Transport Dynamics Using a Novel In Vitro Cerebrospinal Fluid System Analog
,” Front. Neuroimaging
, 1
, p. 879098
.10.3389/fnimg.2022.879098
